Federal clinical recommendations for sarcoidosis diagnosis and treatment: accents and comments

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Sarcoidosis is a multi-organ granulomatosis of unknown origin. Diagnosis and treatment of this disease have not been unified for a long time. In 2022, many authors from three scientific medical communities presented federal clinical guidelines on sarcoidosis, which were approved by the Ministry of Healthcare of Russia in the same year. Current article contains the most important practical aspects of this disease, which include the absence of specific markers, need to compare radiation, clinical, morphological and functional data, the presence of variants of clinical course of sarcoidosis without respiratory damage. It is extremely important for physicians to know and understand when and how to start treatment of sarcoidosis, how to manage patients, avoiding early prescription of hormones and cytostatics and responding in a timely manner to the progression of the disease and the development of life-threatening conditions.

Texto integral

Acesso é fechado

Sobre autores

Alexander Vizel

Kazan State Medical University of the Ministry of Healthcare of Russia

Autor responsável pela correspondência
Email: lordara@inbox.ru
ORCID ID: 0000-0001-5028-5276

md, professor, head of the department of phthisiology and pulmonology

Rússia, 420012, Kazan, 49 Butlerova Str.

Sergey Avdeev

First Moscow State Medical University of the Ministry of Healthcare of Russia (Sechenov University); Research Institute of Pulmonology of FMBA

Email: serg_avdeev@list.ru
ORCID ID: 0000-0002-5999-2150

md, professor, academician of RAS, head of the department of pulmonology, N.V. Sklifosovsky Institute of Clinical Medicine 

Rússia, 107045, Moscow, 3 Bolshaya Sukharevskaya Sq.; Moscow

Andrey Malyavin

Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of Russia

Email: maliavin@mail.ru
ORCID ID: 0000-0002-6128-5914

md, professor, professor of the department of phthisiology and pulmonology

Rússia, 107150, Moscow, 39/1 Losinoosyrovskaya Str.

Evgeny Shmelev

Central Research Institute of Tuberculosis

Email: eishmelev@mail.ru

md, professor, head of the department of differential diagnostics

Rússia, 107564, Moscow, 2 Yauzskaya alley

Irina Vizel

Kazan State Medical University of the Ministry of Healthcare of Russia

Email: tatpulmo@mail.ru
ORCID ID: 0000-0002-8855-8177

md, professor of the Russian academy of natural sciences, associate professor of the department of phthisiology and pulmonology

Rússia, 420012, Kazan, 49 Butlerova Str.

Bibliografia

  1. Саркоидоз. Монография. Под ред. А.А. Визеля (серия монографий Российского респираторного общества; гл. ред. серии – А.Г. Чучалин). М.: Издательский холдинг «Атмосфера». 2010; 416 с. [Sarcoidosis. Monograph. Ed. by Wiesel A.A. (a series of monographs of the Russian Respiratory Society; chief editor of the series – Chuchalin A.G.). Moscow: Publishing holding «Atmosfera”. 2010; 416 pp. (In Russ.)]. ISBN: 978-5-902123-34-7.
  2. Клинические рекомендации. Саркоидоз. Российское респираторное общество, общероссийская общественная организация «Российское научное медицинское общество терапевтов», общероссийская общественная организация «Педиатрическое респираторное общество». Рубрикатор клинических рекомендаций Минздрава России. 2022. ID: 736. Доступ: https://cr.minzdrav.gov.ru/schema/736_1 (дата обращения – 01.08.2023). [Clinical guidelines. Sarcoidosis. Russian Respiratory Society, Russian Scientific Medical Society of Internal Medicine, Pediatric Respiratory Society. Rubricator of clinical guidelines of the Ministry of Healthcare of Russia. 2022. ID: 736. URL: https://cr.minzdrav.gov.ru/schema/736_1 (date of access – 01.08.2023) (In Russ.)].

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
2. Рис. Алгоритм лечения пациентов с саркоидозом

Baixar (403KB)

Declaração de direitos autorais © Bionika Media, 2023

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies